Equities researchers at Brookline Capital Management assumed coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a report issued on Thursday, Benzinga reports. The firm set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at ($0.16) EPS, […]
Stock analysts at Brookline Capital Management initiated coverage on shares of Forte Biosciences (NASDAQ:FBRX – Get Free Report) in a note issued to investors on Thursday, Benzinga reports. The brokerage set a “buy” rating and a $4.00 price target on the stock. Brookline Capital Management also issued estimates for Forte Biosciences’ Q2 2024 earnings at […]
Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Daré Bioscience (NASDAQ:DARE) Announces Earnings Results, Misses Expectations By $0.01 EPS modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
FY2024 EPS Estimates for Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Decreased by Analyst themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.